The society operates four biologics and biosimilars registers; three for adult patients and one for children and young adults.

The data collected from the registers generates vital evidence on patient safety in the long term as well as the efficacy of treatment.

Request registers data for your own research

We encourage our members and external parties to access and analyse the rich registers data sets.

To learn more about the process please get in touch with the registers team.

Submit enquiry